Detalhe da pesquisa
1.
A Gene Expression Signature to Select Hepatocellular Carcinoma Patients for Liver Transplantation.
Ann Surg
; 276(5): 868-874, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35916378
2.
A Fair Chance for Everyone: Total Tumor Volume as a Selection Tool in Liver Transplantation for Hepatocellular Carcinoma.
Dig Surg
; 35(6): 539-548, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29346782
3.
Long-term Results of Domino Liver Transplantation for Hepatocellular Carcinoma Using the "Double Piggy-back" Technique: A 13-Year Experience.
Ann Surg
; 262(5): 749-56; discussion 756, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26583662
4.
Pancreas Rejection in the Artificial Intelligence Era: New Tool for Signal Patients at Risk.
J Pers Med
; 13(7)2023 Jun 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37511684
5.
Abernethy malformation and hepatocellular carcinoma: a serious consequence of a rare disease.
BMJ Case Rep
; 13(1)2020 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31911408
6.
Rare giant: mature cystic teratoma in the liver.
J Surg Case Rep
; 2019(12): rjz347, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31832137
7.
Presentation and Clinical Outcomes of Choledochal Cysts in Children and Adults: A Multi-institutional Analysis.
JAMA Surg
; 150(6): 577-84, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25923827